Topics
January/February 2012 | pennsylvania Avenue Updates
The –25 Modifier: When and Why?
GEORGE A. WILLIAMS, MD
June 12, 2026
Genetic Analysis Links Aspirin Use to Increased Risk of Early and Dry AMD
June 10, 2026
Ethyreal Bio Launches With $101 Million to Advance Potential Disease-Modifying Therapy for TED
AAO Partners with OpenEvidence to Bring Specialty Guidelines Directly Into AI Clinical Workflow
June 9, 2026
Optos Appoints Alexandre Montague as Chief Executive Officer
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
